Should oral glucose tolerance testing be mandatory following acute myocardial infarction?

International Journal of Clinical Practice

Volumn 61, Issue 4, 2007, Pages 680-683

  Jessani, S ^a,c   Gangopadhyay, K ^b   Patel, J V ^a   Lip, G Y H ^a   Millane, T ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FALSE NEGATIVE REACTIONS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33947378734     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01301.x     Document Type: Article

References (23)

1. Norhammar A, Tenerz A, Nilson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-44.
2. Meier JJ, Deifuss S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA. Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction. Dtsch Med Wochenschr 2002; 127: 1123-9.
3. Choi MK, Lee WK, Kim GS et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 175-80.
4. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-72.
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
6. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-7.
7. The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-21.
8. Bartnik M, Ryden L, Ferrari R et al. on behalf of the Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation patients with Coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-90.
9. Alberti KGMM, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
10. WHO Study Group. Diabetes mellitus. Technical report Series 727. Geneva: World Health Organisation, 1985.
11. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13.
12. McKeigue PM, Marmot MG, Adelstein AM et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 1985; 16: 1086-90.
13. Anand SS, Yusuf S, Vuksan V et al. for SHARE Investigators. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-84
14. Hashimoto K, Ikewaki K, Yagi H et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005; 28: 1182-86.
15. Ramachandran A, Chamukuttan S, Immaneni S et al. High incidence of glucose intolerance in Asian-Indian subjects with acute coronary syndrome. Diabetes Care 2000; 28: 2492-96.
16. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91: 1-52.
17. Tenerz A, Norhammar A, Silveira A et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003; 26: 2770-6.
18. Ramaiya KL, Swai ABM, Alberti KGMM, McLarty D. Lifestyle changes decrease rates of glucose intolerance and cardiovascular (CVD) risk factors: a six intervention study in a high risk Hindu Indian sub-community. Diabetologia 1992; 35 (Suppl 1): A60.
19. Pan X-R, Li G-W, Hu Y-H et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes study. Diabetes Care 1997; 20: 537-44.
20. Tuomilehto J, Lindstorm J, Eriksson JG et al. for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
21. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
22. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 1980; 29: 41-9.
23. Deedwania CP, Fonseca AV. Diabetes, prediabetes and cardiovascular risk: shifting the paradigm. Am J Med 2005; 118: 939-47.